Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kodo Tomida

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Nephron. Clinical Practice|December 21, 2006
Prospective randomized study evaluating the efficacy of the spherical adsorptive carbon AST-120 in chronic kidney disease patients with moderate decrease in renal functionTatsuya Shoji, Akira Wada, Kazunori Inoue, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 21, 2011
Guideline-practice gap in the management of predialysis chronic kidney disease mineral bone disorder in JapanTakayuki Hamano, Naohiko Fujii, Isao Matsui, et al.
Kidney International|June 11, 2015
Magnesium modifies the association between serum phosphate and the risk of progression to end-stage kidney disease in patients with non-diabetic chronic kidney diseaseYusuke Sakaguchi, Hirotsugu Iwatani, Takayuki Hamano, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2009
Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in ratsIsao Matsui, Takayuki Hamano, Kodo Tomida, et al.
Bone|December 30, 2008
Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patientsKodo Tomida, Takayuki Hamano, Satoshi Mikami, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 12, 2014
Comparison of methylprednisolone plus prednisolone with prednisolone alone as initial treatment in adult-onset minimal change disease: a retrospective cohort studyMaki Shinzawa, Ryohei Yamamoto, Yasuyuki Nagasawa, et al.
BMC Nephrology|October 13, 2020
Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A<sub>2</sub> receptor antibody-positive idiopathic membranous nephropathy: a case reportRei Iio, Shin'ichi Akiyama, Kensuke Mitsumoto, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 25, 2012
Combined use of vitamin D status and FGF23 for risk stratification of renal outcomeChikako Nakano, Takayuki Hamano, Naohiko Fujii, et al.
Kidney International Reports|March 30, 2026
Serial Ultrastructural or Proteomic Observations in Light- and Heavy-Chain Deposition DiseaseSeiji Kakiuchi, Ikumi Takagi, Naru Tomigaki, et al.
Clinical and Experimental Nephrology|March 21, 2013
Age and prediction of remission and relapse of proteinuria and corticosteroid-related adverse events in adult-onset minimal-change disease: a retrospective cohort studyMaki Shinzawa, Ryohei Yamamoto, Yasuyuki Nagasawa, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Nephron. Clinical Practice|December 21, 2006
Prospective randomized study evaluating the efficacy of the spherical adsorptive carbon AST-120 in chronic kidney disease patients with moderate decrease in renal functionTatsuya Shoji, Akira Wada, Kazunori Inoue, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 21, 2011
Guideline-practice gap in the management of predialysis chronic kidney disease mineral bone disorder in JapanTakayuki Hamano, Naohiko Fujii, Isao Matsui, et al.
Kidney International|June 11, 2015
Magnesium modifies the association between serum phosphate and the risk of progression to end-stage kidney disease in patients with non-diabetic chronic kidney diseaseYusuke Sakaguchi, Hirotsugu Iwatani, Takayuki Hamano, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2009
Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in ratsIsao Matsui, Takayuki Hamano, Kodo Tomida, et al.
Bone|December 30, 2008
Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patientsKodo Tomida, Takayuki Hamano, Satoshi Mikami, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 12, 2014
Comparison of methylprednisolone plus prednisolone with prednisolone alone as initial treatment in adult-onset minimal change disease: a retrospective cohort studyMaki Shinzawa, Ryohei Yamamoto, Yasuyuki Nagasawa, et al.
BMC Nephrology|October 13, 2020
Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A<sub>2</sub> receptor antibody-positive idiopathic membranous nephropathy: a case reportRei Iio, Shin'ichi Akiyama, Kensuke Mitsumoto, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 25, 2012
Combined use of vitamin D status and FGF23 for risk stratification of renal outcomeChikako Nakano, Takayuki Hamano, Naohiko Fujii, et al.
Kidney International Reports|March 30, 2026
Serial Ultrastructural or Proteomic Observations in Light- and Heavy-Chain Deposition DiseaseSeiji Kakiuchi, Ikumi Takagi, Naru Tomigaki, et al.
Clinical and Experimental Nephrology|March 21, 2013
Age and prediction of remission and relapse of proteinuria and corticosteroid-related adverse events in adult-onset minimal-change disease: a retrospective cohort studyMaki Shinzawa, Ryohei Yamamoto, Yasuyuki Nagasawa, et al.
Pageof 3